MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

497949

Report Date :

15.03.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

VITAL LABORATORIES PRIVATE LIMITED (w.e.f. 01.11.2016)

 

 

Formerly Known As :

VITAL HEALTH CARE PRIVATE LIMITED

 

 

Registered Office :

2nd Floor, Plot No. 48, Service Road, Western Express Highway,  Near Hanuman Temple (N.H.8), Vile Parle (East), Mumbai – 400057, Maharashtra

Tel. No.:

91-22-26183641/26136946

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

19.01.1998

 

 

Com. Reg. No.:

11-113058

 

 

Capital Investment / Paid-up Capital :

INR 87.530 Million

 

 

CIN No.:

[Company Identification No.]

U24100MH1998PTC113058

 

 

IEC No.:

[Import-Export Code No.]

0398063371

 

 

CST/ TIN No.:

27741466763

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACV3964F

 

 

GSTN :

[Goods & Service Tax Registration No.]

27AAACV3964F2Z7

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

  • Manufacturer and supplier of traditional and new generational API to the National and International pharmaceutical community by offering stable and high quality products, on continuous innovation and development. (Registered Activity)

 

  • Manufacturer, Exporter, Importer and Supplier of Active Pharmaceutical Ingredients (API). (Confirmed by management)

 

 

No. of Employees :

400 (Approximately)

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Maximum Credit Limit :

USD 3657000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Vital Laboratories Private Limited was incorporated in the year 1998.

 

As per available financials for the year 2017, the company has achieved revenue growth of 26.66% as compared to the previous year along with a profit margin of 12.67%.

 

The sound financial risk profile of the company is marked by adequate net worth base along with strong debt protection metrics due to negligible debt level.

 

Rating takes into account the subject’s long established track record of business operations along with extensive experience of its promoters.

 

Payments seems to be regular.

 

In view of aforesaid, the company can be considered good for normal business dealings at usual trade terms and conditions.

 

Note: The company Vital Laboratories Private Limited [CIN No.: U24230MH2002PTC136195] has been amalgamated and merged with Vital Health Care Private Limited [CIN No:  U24230MH1998PTC113058] in June 2015 after that the name of the amalgamated company has been changed to “Vital Laboratories Private Limited” [CIN No.: U74110MH1998PTC113058] in November 2016. Later, the CIN number of the subject changed from U74110MH1998PTC113058 to U24100MH1998PTC113058.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Borrowing=BBB+

Rating Explanation

Moderate degree of safety and moderate credit risk.

Date

31.08.2017

 

Rating Agency Name

CRISIL

Rating

Short Term Borrowing=A2

Rating Explanation

Strong degree of safety and low credit risk.

Date

31.08.2017

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 15.03.2018

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Sachin Tammewar

Designation :

Assistant Manager Finance

Contact No.:

91-22-26183641

 

 

LOCATIONS

 

Registered Office/ Corporate Office :

2nd Floor, Plot No. 48, Service Road, Western Express Highway,  Near Hanuman Temple (N.H.8), Vile Parle (East), Mumbai – 400057, Maharashtra, India

Tel. No.:

91-22-26183641/26136946

Fax No.:

91-22-26136945

E-Mail :

vital@vhcpl.com

srbajaj@vhcpl.com

Website :

www.vitalhealthcare.in 

www.vitallab.in

http://www.vitallab.com

Location :

Rented

Locality :

Commercial

 

 

Factory 1:

Plot No. 1710 and A1/2208, G.I.D.C. Estate, Phase III, Vapi – 396195 Gujarat, India

Fax No.:

91-260-2401497

 

 

Factory 2:

Plot No. 1416-21, 1507, 1601, 1601/3 and 4, G.I.D.C. Estate, Phase III, Vapi – 396 195 Gujarat, India

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Laltaprasad Shreenath Maurya

Designation :

Director

Address :

Ashok Nagar, Chanod Colony, Vapi-396195, Gujarat, India

Date of Birth/Age :

26.07.1955

Qualification :

B.A

Date of Appointment :

15.05.2015

PAN No.:

AMEPM0790M

DIN No.:

00202949

Other Directorship :

 

Other Directorship :

Other Directorship :

Other Directorship :

Other Directorship :

U24230MH2002PTC136195

VITAL LABORATORIES PRIVATE LIMITED

24/04/2009

-

U24230MH2003PTC143328

VITAL LIFESCIENCES PRIVATE LIMITED

31/03/2006

-

 

 

Name :

Mr. Anil Balkrishna Ghogare

Designation :

Director

Address :

Flat No 104, 1st Floor, Rajanigandha Corporate Housing Society, Plot No 106, Gorai 2, Borivali (West), Mumbai-400091, Maharashtra, India

Date of Birth/Age :

01.06.1960

Qualification :

MBA, PHD

Date of Appointment :

21.09.2014

PAN No.:

AFGPG6904A

DIN No.:

00432659

Other Directorship :

 

CIN/FCRN

Company Name

Begin Date

End Date

U24110MH1985PTC035004

UNIMAX LABORATORIES PRIVATE LIMITED

02/05/2005

-

U24230MH2002PTC136195

VITAL LABORATORIES PRIVATE LIMITED

30/09/2013

-

 

 

Name :

Mr. Shrigopal Rangnath Bajaj

Designation :

Director

Address :

Venkatesh, Mahant Road Extension, Uttkarsh Mandal Circle, Vile Parle (East), Mumbai-400057, Maharashtra, India

Date of Birth/Age :

04.01.1943

Qualification :

B SC

Date of Appointment :

31.03.2001

PAN No.:

AAAPB7785R

DIN No.:

00983198

Other Directorship :

 

CIN/FCRN

Company Name

Begin Date

End Date

U24200MH1981PTC023725

PADMA PHARMACEUTICALS PRIVATE LIMITED

21/01/1981

-

U24230MH2002PTC136195

VITAL LABORATORIES PRIVATE LIMITED

22/06/2012

-

U24230MH2003PTC143328

VITAL LIFESCIENCES PRIVATE LIMITED

01/09/2005

-

U45400MH2007PTC271966

NIGHTANGLE CONSTRUCTION PRIVATE LIMITED

01/11/2011

-

U18101MH2007PTC270415

TRIVINI TRADERS PRIVATE LIMITED

01/11/2011

-

U51109MH2008PTC249051

NABARATNA VINIMAY PRIVATE LIMITED

09/04/2010

-

U74999MH2017NPL295383

VITAL GLOBAL FOUNDATION

25/05/2017

-

 

 

Name :

Mr. Rajiv Shrigopal Bajaj

Designation :

Director

Address :

Venkatesh, 2nd Floor, Mahant Road. Extention, Uttkarsh Mandal Circle, Vileparle – (East), Mumbai-400057, Maharashtra, India

Date of Birth/Age :

10.01.1965

Qualification :

B SC

Date of Appointment :

31.03.2001

PAN No.:

AAEPB3748C

DIN No.:

01659971

Other Directorship :

 

CIN/FCRN

Company Name

Begin Date

End Date

U24200MH1981PTC023725

PADMA PHARMACEUTICALS PRIVATE LIMITED

22/12/1983

-

U24230MH2002PTC136195

VITAL LABORATORIES PRIVATE LIMITED

13/06/2002

-

U24230MH2003PTC143328

VITAL LIFESCIENCES PRIVATE LIMITED

01/09/2005

-

U45400MH2007PTC271966

NIGHTANGLE CONSTRUCTION PRIVATE LIMITED

01/11/2011

-

U18101MH2007PTC270415

TRIVINI TRADERS PRIVATE LIMITED

01/11/2011

-

U51109MH2008PTC249051

NABARATNA VINIMAY PRIVATE LIMITED

09/04/2010

-

U74999MH2017NPL295383

VITAL GLOBAL FOUNDATION

25/05/2017

-

 

 

 

 

KEY EXECUTIVES

 

Name :

Mr. Ninad Vijay Sawant

Designation :

Company Secretary

Address :

407/B, Shetrunji Apartment, Sahakar Gram Ashok Nagar, Kandivali (East), Mumbai-400101, Maharashtra, India

Date of Appointment :

01.08.2017

PAN No.:

CGZPS6622R

 

 

Name :

Mr. Sachin Tammewar

Designation :

Assistant Manager Finance

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2017

 

Names of Shareholders

 

No. of Shares

Dipika R. Bajaj

 

684856

Ginni Devi Bajaj

 

972126

Rajiv S. Bajaj

 

1283958

Rajiv S. Bajaj (HUF)

 

581850

Shrigopal R. Bajaj

 

1126500

Shrigopal R. Bajaj (HUF)

 

752362

Padma Pharmaceuticals Private Limited

 

2872701

L. P. Maurya

 

1750

Nabaratna Vinimay Private Limited

 

476595

Vijay Saraf

 

297

Total

 

8752995

 

As on 26.05.2017

 

Names of Allottee

 

No. of Shares

Padma Pharmaceuticals Private Limited

 

357142

Total

 

357142

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2017

 

Category

Percentage

Promoters (Individual/Hindu Undivided Family-Indian)

61.74

Promoters (Body corporate)

38.26

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

  • Manufacturer and supplier of traditional and new generational API to the National and International pharmaceutical community by offering stable and high quality products, on continuous innovation and development. (Registered Activity)

 

  • Manufacturer, Exporter, Importer and Supplier of Active Pharmaceutical Ingredients (API). (Confirmed by management)

 

 

Products/ Services :

Item Code No.

Product/ Services Description

29420090

Hyoscine Butyl Bromide, MCB, Thiocolchicoside, 10 DAB, others

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

 

Products :

Finished Goods

Countries :

  • United Kingdom
  • United States of America

 

 

Imports :

 

Products :

Raw Material

Countries :

  • China
  • Australia
  • Netherland

 

 

Terms :

 

Selling :

Cheque and Others (NEFT/ RTGS)

 

 

Purchasing :

Cheque and Others (NEFT/ RTGS)

 

PRODUCTION STATUS NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Hebei Yuxing Bio-Engineering Company Limited

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

End Users

Reference :

ICPA Laboratories Limited

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

400 (Approximately)

 

 

Bankers :

Bank Name

DBS Bank Limited

Branch

2nd Floor, Shree Ambica Auto GIDC Bhatpore, Opposite ONGC Hazira, Surat – 394510, Gujarat, India

Person Name (With Designation)

--

Contact Number

--

Name of Account Holder

--

Account Number

--

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

--

Account Operation

--

Remarks (If any)

--

 

  • The Saraswat Co-Operative Bank Limited, Andheri East Branch, 33 Shiv Chhaya Sir MV Road, Opposite Arasa Hotel, Andheri (East), Mumbai – 400069, Maharashtra, India

 

  • ICICI Bank Limited, ICICI Bank Tower, Near Chakli Circle, Old Padra Road, Vadodara – 390007, Gujarat, India

 

 

Facilities :

Secured Loan

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Non-convertible debentures banks

185.200

0.000

Rupee term loans from banks

92.182

92.147

Loans taken for vehicles

10.889

14.938

Short-term borrowings

 

 

Rupee term loans from banks

501.311

845.494

Total

789.582

952.579

 

Auditors :

 

Name :

Shantilal Chandaliya and Company

Chartered Accountants

Address :

G-6/7, Amit Industrial Estate, Dr. S.S. Rao Road, , Near Citi Tower, Parel (East), Mumbai – 400012, Maharashtra, India

Income-tax PAN of auditor or auditor's firm :

AAXFS7579M

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

  • Padma Pharmaceuticals Private Limited
  • Rajiv S. Bajaj HUF
  • S.R.Bajaj (HUF)
  • Redpaw Pte Limited
  • Pidi Standard Biotech (Chonging) Limited
  • Vital Lifesciences Private Limited
  • Nabaratna Vinimay Private Limited
  • Triveni Traders Private Limited
  • Nightangle Constructions Private Limited
  • PPPL (Mauritius) Private Limited

 

 

CAPITAL STRUCTURE

 

After 30.09.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

9500000

Equity Shares

INR 10/- each

INR 95.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

9110137

Equity Shares

INR 10/- each

INR 91.101 Million

 

 

 

 

 

As on 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

9500000

Equity Shares

INR 10/- each

INR 95.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

8752995

Equity Shares

INR 10/- each

INR 87.530 Million

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

87.530

87.530

79.625

(b) Reserves and Surplus

1157.681

769.743

688.638

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

35.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1280.211

857.273

768.263

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

573.469

433.430

440.392

(b) Deferred tax liabilities (Net)

80.481

54.639

36.665

(c) Other long-term liabilities

0.000

0.000

0.000

(d) long-term provisions

4.088

3.694

3.068

Total Non-current Liabilities (3)

658.038

491.763

480.125

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

501.311

845.494

887.039

(b) Trade payables

275.910

274.305

199.394

(c) Other current liabilities

281.517

177.101

179.716

(d) Short-term provisions

0.508

6.436

20.828

Total Current Liabilities (4)

1059.246

1303.336

1286.977

 

 

 

 

TOTAL

2997.495

2652.372

2535.365

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1171.270

893.984

732.429

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Tangible assets capital work-in-progress

53.827

17.830

52.103

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.030

0.030

0.030

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term loans and advances

34.868

37.755

32.709

(e) Other Non-current assets

11.629

8.086

6.338

Total Non-Current Assets

1271.624

957.685

823.609

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

720.585

946.773

997.040

(c) Trade receivables

717.250

486.863

364.556

(d) Cash and bank balances

111.114

105.975

91.563

(e) Short-term loans and advances

120.991

133.156

181.034

(f) Other current assets

55.931

21.920

77.563

Total Current Assets

1725.871

1694.687

1711.756

 

 

 

 

TOTAL

2997.495

2652.372

2535.365

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Total Revenue from operations

3062.746

2417.969

2294.749

 

Other Income

8.043

15.075

18.658

 

TOTAL

3070.789

2433.044

2313.407

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

1455.711

1463.803

1490.808

 

Purchases of Stock-in-Trade

0.000

0.000

0.000

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

173.566

170.987

94.144

 

Employee benefit expense

205.017

124.284

109.916

 

CSR expenditure

0.061

0.000

0.000

 

Other expenses

479.426

324.933

277.621

 

TOTAL

2313.781

2084.007

1972.489

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

757.008

349.037

340.918

 

 

 

 

 

Less

FINANCIAL EXPENSES

103.342

127.778

133.897

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

653.666

221.259

207.021

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

111.703

97.649

84.669

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

541.963

123.610

122.352

 

 

 

 

 

Less

TAX

154.025

34.600

26.490

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

387.938

89.010

95.862

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

44.32

10.17

12.04

 

Expected Sales (2017-2018) : INR 3600.000 Million

 

The above information has been parted by Mr. Sachin Tammewar (Assistant Manager Finance)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

103.546

82.067

89.207

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

727.453

304.474

250.960

Net cash flow from operating activity

692.613

406.504

346.831

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

85.48

73.49

57.99

 

 

 

 

Account Receivables Turnover

( Income / Sundry Debtors)

4.27

4.97

6.29

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

69.18

68.40

48.82

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

1.05

0.37

0.34

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.62

0.38

0.43

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.58

0.69

0.72

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.92

1.59

1.84

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.83

1.52

1.68

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.96

1.06

1.02

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

7.33

2.73

2.55

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

[(PAT / Sales) * 100]

%

12.67

3.68

4.18

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

12.94

3.36

3.78

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

30.30

10.38

12.48

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.63

1.30

1.33

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.95

0.57

0.56

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.43

0.32

0.30

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

13.46

15.55

17.79

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.63

1.30

1.33

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

79.625

87.530

87.530

Reserves & Surplus

688.638

769.743

1157.681

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

35.000

Net worth

768.263

857.273

1280.211

 

 

 

 

Long-term borrowings

440.390

433.429

573.469

Short term borrowings

887.039

845.494

501.311

Current maturities of long-term debts

89.207

82.067

103.546

Total borrowings

1416.636

1360.990

1178.326

Debt/Equity ratio

1.844

1.588

0.920

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

2294.749

2417.969

3062.746

 

 

5.370

26.666

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

2294.749

2417.969

3062.746

Profit/ (Loss)

95.862

89.010

387.938

 

4.18%

3.68%

12.67%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

Yes

19

Major customers

Yes

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

Yes

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

 

COMPANY INFORMATION

 

The Company is a leading manufacturer and supplier of traditional and new generational API to the National and International pharmaceutical community by offering stable and high quality products, on continuous innovation and development.

 

Within a span of 20 years it has evolved itself into a plant covering area of 24,757 sq. mtr. of land with building of 3,10,336 sq. feet and manufacturing 525 Tons p.a. with an impressive clientele list of all major Indian Pharmaceutical companies and exporters of formulations. With exports being done to all continents, we have become a force to reckon with.

 

Financial Strength, Reliable indigenous technology flavored with Constant innovation, a keen mind open to new ideas and experiments coupled with Crystal Clear business practices and self confidence brimming to the hilt are VITAL secrets of this stupendous growth.

 

 

OPERATIONS

 

The Company has reported total revenue of INR 3070.789 Million for the current year as compared to INR 2433.044 Million in the previous year. The Net Profit for the year amounted to INR 387.938 Million in the current year as compared to INR 89.010 Million in the previous year.

 

 

CHANGE IN THE NATURE OF BUSINESS:

 

There is no material change in the Nature of Business being done by the company in the year under reporting as compared to the previous ended 31.03.2016. During the year company has taken initative to go green by setting up a 2MW Wind Mill project in Rojmal, Gujarat. Company is confident that this step will contribute towards saving the climate change. During the year, the Company completed the process of merger with Vital Laboratories Private Limited (Amalgamated company) CIN: U24230MH2002PTC136195.

 

 

CHANGE IN SHARE CAPITAL

 

During the year the company has issued 4950995 shares pursuant to the scheme of Amalgamation on 12/09/2016.

 

 

UNSECURED LOAN

 

PARTICULARS

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Loans and advances from directors

80.857

74.975

Loans and advances from others

204.341

251.370

Total

285.198

326.345

 

 

 

INDEX OF CHARGES

 

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

AMOUNT

ADDRESS

1

G75235663

100150472

DBS BANK LIMITED

11/01/2018

120000000.0

2ND FLOOR, SHREE AMBICA AUTO GIDC BHATPORE, OPPOSITE ONGC HAZIRA, SURAT – 394510, GUJARAT, INDIA

2

G75237297

100150479

DBS BANK LIMITED

11/01/2018

280000000.0

2ND FLOOR, SHREE AMBICA AUTO GIDC BHATPORE, OPPOSITE ONGC HAZIRA, SURAT – 394510, GUJARAT, INDIA

3

G42254441

100093304

SIEMENS FINANCIAL SERVICES PRIVATE LIMITED

31/03/2017

51988070.0

130, PANDURANG BUDHKAR MARG, WORLI MUMBAI – 400018, MAHARASHTRA, INDIA

4

G42670950

100094313

SIEMENS FINANCIAL SERVICES PRIVATE LIMITED

30/03/2017

23396969.0

130, PANDURANG BUDHKAR MARG, WORLI MUMBAI – 400018, MAHARASHTRA, INDIA

5

G41989526

100092515

ICICI BANK LIMITED

25/03/2017

500000000.0

ICICI BANK TOWER, NEAR CHAKLI CIRCLE, OLD PADRA ROAD, VADODARA – 390007, GUJARAT INDIA

6

G41351453

100090709

THE SARASWAT CO-OP BANK LTD

22/03/2017

15000000.0

ANDHERI EAST BRANCH, 33 SHIV CHHAYA SIR MV ROAD OPPOSITE ARASA HOTEL ANDHERI (EAST), MUMBAI – 400069, MAHARASHTRA, INDIA

7

G35980655

100077420

SIEMENS FINANCIAL SERVICES PRIVATE LIMITED

27/01/2017

9466875.0

130, PANDURANG BUDHKAR MARG, WORLI MUMBAI – 400018, MAHARASHTRA INDIA

8

G35980333

100077419

SIEMENS FINANCIAL SERVICES PRIVATE LIMITED

30/12/2016

18116857.0

130, PANDURANG BUDHKAR MARG, WORLI MUMBAI – 400018, MAHARASHTRA INDIA

9

C50531813

10562521

SIEMENS FINANCIAL SERVICES PRIVATE LIMITED

31/03/2015

13500000.0

130, PANDURANG BUDHKAR MARG, WORLI MUMBAI – 400018, MAHARASHTRA INDIA

10

B89476568

10460058

AXIS BANK LIMITED

09/11/2013

1249000.0

TRISHUL 3RD FLOOR OPPOSITE SAMARTHESHWAR TEMPLELAW GARDEN ELLISBRIDGE AHMEDABAD – 380006, GUJARAT, INDIA

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Motor vehicles
  • Office equipment
  • Computer equipments

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 64.98

UK Pound

1

INR 90.82

Euro

1

INR 80.09

 

 

INFORMATION DETAILS

 

Analysis Done by :

PRI

 

 

Report Prepared by :

SUD

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.